Compare ZLAB & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | SFL |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | China | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.5B |
| IPO Year | 2017 | 2004 |
| Metric | ZLAB | SFL |
|---|---|---|
| Price | $18.40 | $10.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $49.60 | $12.00 |
| AVG Volume (30 Days) | 867.0K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 7.05% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $9.75 | N/A |
| Revenue Next Year | $26.03 | $13.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $6.73 |
| 52 Week High | $41.20 | $12.94 |
| Indicator | ZLAB | SFL |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 35.98 |
| Support Level | $18.29 | $10.57 |
| Resistance Level | $19.49 | $11.15 |
| Average True Range (ATR) | 0.65 | 0.24 |
| MACD | 0.23 | -0.04 |
| Stochastic Oscillator | 77.19 | 22.10 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities. The company operates as a single reportable segment, generating revenue from long-term, fixed-rate charters. Its Additional revenue sources include sales-type lease interest income, voyage charter and pool revenues, and drilling contract revenues.